Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)
Nexalin Technology (NXL) posted Accumulated Expenses of $858504.0 for Q2 2026, up 34.09% on a QoQ basis from $640265.0 in Q1 2026, and up 138.47% year-over-year from $360004.0 in Q2 2025.
Analysis
Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Accumulated Expenses for 6 years, with the latest figure at $858504.0 in Q2 2026.
- On a quarterly basis, Accumulated Expenses rose 138.47% year-over-year to $858504.0 in Q2 2026; TTM through Jun 2026 was $858504.0, a 138.47% increase from a year earlier, with the FY2025 full-year figure at $642754.0, up 64.49% from the prior year.
- Accumulated Expenses was $858504.0 for Q2 2026 at Nexalin Technology, up from $640265.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $858504.0 in Q2 2026, with the low at $124966.0 in Q2 2024.
- Average Accumulated Expenses over 5 years is $452560.1, with a median of $417921.5 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 79.3% in 2024, then surged 188.08% in 2025.
- Over 5 years, Accumulated Expenses stood at $539822.0 in 2022, then tumbled by 51.6% to $261284.0 in 2023, then surged by 49.55% to $390745.0 in 2024, then surged by 64.49% to $642754.0 in 2025, then jumped by 33.57% to $858504.0 in 2026.
- The last three Accumulated Expenses figures came in at $858504.0 (Q2 2026), $640265.0 (Q1 2026), and $642754.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 858,504.00 |
| Mar 31, 2026 | 640,265.00 |
| Dec 31, 2025 | 642,754.00 |
| Sep 30, 2025 | 290,031.00 |
| Jun 30, 2025 | 360,004.00 |
| Mar 31, 2025 | 393,342.00 |
| Dec 31, 2024 | 390,745.00 |
| Sep 30, 2024 | 132,847.00 |
| Jun 30, 2024 | 124,966.00 |
| Mar 31, 2024 | 355,713.00 |
| Dec 31, 2023 | 261,284.00 |
| Sep 30, 2023 | 606,891.00 |
| Jun 30, 2023 | 603,633.00 |
| Mar 31, 2023 | 597,660.00 |
| Dec 31, 2022 | 539,822.00 |
| Sep 30, 2022 | 442,501.00 |
| Dec 31, 2021 | 611,795.00 |